(6-Bromo-4-(3-(2-(pyrrolidin-1-yl)ethyl)phenylamino)quinolin-3-yl)(cyclopropyl)methanone → HCID 66715697, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:23]=[CH:22][CH:21]=[C:20]([CH2:24][CH2:25][N:26]2[CH2:30][CH2:29][CH2:28][CH2:27]2)[CH:19]=1.[Cl:31][C:32]1[CH:37]=[C:36](B2OC(C)(C)C(C)(C)O2)[CH:35]=[C:34]([F:47])[C:33]=1[OH:48]>>[ClH:31].[Cl:31][C:32]1[CH:37]=[C:36]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12]([CH:14]2[CH2:16][CH2:15]2)=[O:13])=[C:5]3[NH:17][C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([CH2:24][CH2:25][N:26]3[CH2:27][CH2:28][CH2:29][CH2:30]3)[CH:19]=2)[CH:35]=[C:34]([F:47])[C:33]=1[OH:48]Participants
Procedure
Following general procedure F, (6-bromo-4-(3-(2-(pyrrolidin-1-yl)ethyl)phenylamino)quinolin-3-yl)(cyclopropyl)methanone (45 mg, 0.097 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (40 mg, 0.15 mmol) to obtain the desired product which was dissolved in methanol and HCl (2 mL, 1.25 M in methanol). The mixture was concentrated to obtain the desired product (46 mg, 79% over two steps) as a yellow solid: 1H NMR (500 MHz, CD3OD) δ 9.44 (s, 1H), 8.23 (dd, J=8.8, 1.9 Hz, 1H), 8.02 (d, J=8.8 Hz, 1H), 7.92 (s, 1H), 7.65-7.57 (m, 1H), 7.56-7.47 (m, 2H), 7.41-7.35 (m, 1H), 7.16-7.10 (m, 1H), 6.97 (s, 1H), 3.71-3.65 (m, 2H), 3.46-3.39 (m, 2H), 3.19-3.06 (m, 4H), 2.91-2.87 (m, 1H), 2.19-2.09 (m, 2H), 2.06-2.00 (m, 2H), 1.26-1.15 (m, 4H); ESI MS m/z 530 [C31H29ClFN3O2+H]+; HPLC 98.4% (AUC), tR=10.81 min.
Sources & evidence
- ORD record
- ord-fbbea5069f4d401eaacda3dc89998aad
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…